NeoPharm CO., LTD. (092730.KQ)
KRW 12780.0
(-4.91%)
KRW 12780.0
(-4.91%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 97.1 Billion KRW | 14.2% |
| 2022 | 85.03 Billion KRW | -3.3% |
| 2021 | 87.93 Billion KRW | 7.72% |
| 2020 | 81.62 Billion KRW | -1.94% |
| 2019 | 83.24 Billion KRW | 25.6% |
| 2018 | 66.27 Billion KRW | 23.57% |
| 2017 | 53.63 Billion KRW | 26.59% |
| 2016 | 42.36 Billion KRW | 17.81% |
| 2015 | 35.96 Billion KRW | 0.0% |
| 2014 | 25.6 Billion KRW | N/A |
| 2013 | 20.13 Billion KRW | N/A |
| 2012 | 18.77 Billion KRW | 0.0% |
| 2011 | 16.94 Billion KRW | N/A |
| 2010 | 14.66 Billion KRW | N/A |
| 2009 | 14.6 Billion KRW | N/A |
| 2008 | 12.47 Billion KRW | N/A |
| 2007 | 5.76 Billion KRW | N/A |
| 2006 | 11.45 Billion KRW | N/A |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 28.21 Billion KRW | 3.68% |
| 2024 Q3 | 26.15 Billion KRW | -14.6% |
| 2024 Q2 | 30.62 Billion KRW | 8.53% |
| 2023 Q1 | 23.58 Billion KRW | 5.39% |
| 2023 Q4 | 27.21 Billion KRW | 24.79% |
| 2023 FY | 97.1 Billion KRW | 14.2% |
| 2023 Q2 | 24.49 Billion KRW | 3.87% |
| 2023 Q3 | 21.8 Billion KRW | -10.98% |
| 2022 Q2 | 21.47 Billion KRW | -3.88% |
| 2022 Q4 | 22.37 Billion KRW | 18.85% |
| 2022 FY | 85.03 Billion KRW | -3.3% |
| 2022 Q3 | 18.82 Billion KRW | -12.34% |
| 2022 Q1 | 22.34 Billion KRW | -7.47% |
| 2021 Q4 | 24.15 Billion KRW | 24.18% |
| 2021 Q3 | 19.44 Billion KRW | -9.02% |
| 2021 FY | 87.93 Billion KRW | 7.72% |
| 2021 Q2 | 21.37 Billion KRW | -6.88% |
| 2021 Q1 | 22.95 Billion KRW | -0.29% |
| 2020 Q2 | 21.38 Billion KRW | 10.85% |
| 2020 FY | 81.62 Billion KRW | -1.94% |
| 2020 Q4 | 23.02 Billion KRW | 28.47% |
| 2020 Q1 | 19.29 Billion KRW | -15.41% |
| 2020 Q3 | 17.92 Billion KRW | -16.22% |
| 2019 FY | 83.24 Billion KRW | 25.6% |
| 2019 Q4 | 22.8 Billion KRW | 19.27% |
| 2019 Q1 | 19.85 Billion KRW | 3.52% |
| 2019 Q2 | 21.45 Billion KRW | 8.04% |
| 2019 Q3 | 19.12 Billion KRW | -10.84% |
| 2018 Q1 | 16.62 Billion KRW | 3.62% |
| 2018 FY | 66.27 Billion KRW | 23.57% |
| 2018 Q3 | 14.37 Billion KRW | -10.63% |
| 2018 Q2 | 16.08 Billion KRW | -3.26% |
| 2018 Q4 | 19.18 Billion KRW | 33.4% |
| 2017 Q1 | 13.08 Billion KRW | 7.45% |
| 2017 FY | 53.63 Billion KRW | 26.59% |
| 2017 Q2 | 13.02 Billion KRW | -0.47% |
| 2017 Q3 | 11.47 Billion KRW | -11.94% |
| 2017 Q4 | 16.04 Billion KRW | 39.92% |
| 2016 Q3 | 8.44 Billion KRW | -10.66% |
| 2016 FY | 42.36 Billion KRW | 17.81% |
| 2016 Q2 | 9.45 Billion KRW | -23.11% |
| 2016 Q4 | 12.18 Billion KRW | 44.25% |
| 2016 Q1 | 12.29 Billion KRW | -4.77% |
| 2015 Q2 | 6.77 Billion KRW | 0.0% |
| 2015 FY | 35.96 Billion KRW | 0.0% |
| 2015 Q3 | 7.34 Billion KRW | 8.39% |
| 2015 Q4 | 12.9 Billion KRW | 75.73% |
| 2013 Q2 | 4.43 Billion KRW | -20.64% |
| 2013 Q1 | 5.59 Billion KRW | -4.78% |
| 2013 Q3 | 3.44 Billion KRW | -22.29% |
| 2012 Q4 | 5.87 Billion KRW | 0.0% |
| 2012 FY | 18.77 Billion KRW | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Kolmar BNH Co., Ltd. | 579.55 Billion KRW | 83.245% |